Compare AANJANEYA LIFECARE with Piramal Enterprises - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs PIRAMAL ENTERPRISES - Comparison Results

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS PIRAMAL ENTERPRISES DR. DATSONS LABS/
PIRAMAL ENTERPRISES
 
P/E (TTM) x -10.9 -48.7 - View Chart
P/BV x 0.2 1.6 9.9% View Chart
Dividend Yield % 0.0 1.4 -  

Financials

 DR. DATSONS LABS   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
PIRAMAL ENTERPRISES
Mar-19
DR. DATSONS LABS/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs1263,303 3.8%   
Low Rs311,797 1.7%   
Sales per share (Unadj.) Rs133.0716.5 18.6%  
Earnings per share (Unadj.) Rs0.279.7 0.2%  
Cash flow per share (Unadj.) Rs6.6107.9 6.1%  
Dividends per share (Unadj.) Rs028.00 0.0%  
Dividend yield (eoy) %01.1 0.0%  
Book value per share (Unadj.) Rs128.81,477.5 8.7%  
Shares outstanding (eoy) m31.66184.45 17.2%   
Bonus/Rights/Conversions FCCBIS-  
Price / Sales ratio x0.63.6 16.5%   
Avg P/E ratio x516.132.0 1,613.4%  
P/CF ratio (eoy) x11.823.6 50.1%  
Price / Book Value ratio x0.61.7 35.2%  
Dividend payout %035.1 0.0%   
Avg Mkt Cap Rs m2,477470,292 0.5%   
No. of employees `000NA7.8 0.0%   
Total wages/salary Rs m5622,504 0.2%   
Avg. sales/employee Rs ThNM16,899.4-  
Avg. wages/employee Rs ThNM2,877.7-  
Avg. net profit/employee Rs ThNM1,879.9-  
INCOME DATA
Net Sales Rs m4,211132,153 3.2%  
Other income Rs m793,128 2.5%   
Total revenues Rs m4,289135,281 3.2%   
Gross profit Rs m56966,290 0.9%  
Depreciation Rs m2045,202 3.9%   
Interest Rs m43044,097 1.0%   
Profit before tax Rs m1320,119 0.1%   
Minority Interest Rs m03,194 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m68,611 0.1%   
Profit after tax Rs m514,701 0.0%  
Gross profit margin %13.550.2 26.9%  
Effective tax rate %48.042.8 112.2%   
Net profit margin %0.111.1 1.0%  
BALANCE SHEET DATA
Current assets Rs m6,852122,742 5.6%   
Current liabilities Rs m6,711310,810 2.2%   
Net working cap to sales %3.3-142.3 -2.4%  
Current ratio x1.00.4 258.5%  
Inventory Days Days16123 697.3%  
Debtors Days Days31839 820.0%  
Net fixed assets Rs m3,673116,904 3.1%   
Share capital Rs m317369 85.8%   
"Free" reserves Rs m3,761272,161 1.4%   
Net worth Rs m4,078272,530 1.5%   
Long term debt Rs m1,671270,196 0.6%   
Total assets Rs m12,633856,261 1.5%  
Interest coverage x1.01.5 70.7%   
Debt to equity ratio x0.41.0 41.3%  
Sales to assets ratio x0.30.2 216.0%   
Return on assets %3.46.9 50.1%  
Return on equity %0.15.4 2.2%  
Return on capital %7.712.4 61.8%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96415,200 6.3%   
Fx outflow Rs m6074,889 12.4%   
Net fx Rs m35710,312 3.5%   
CASH FLOW
From Operations Rs m1,345-115,975 -1.2%  
From Investments Rs m-2,256-8,265 27.3%  
From Financial Activity Rs m-1,200107,525 -1.1%  
Net Cashflow Rs m-2,111-16,650 12.7%  

Share Holding

Indian Promoters % 4.5 52.9 8.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.0 -  
FIIs % 1.4 26.6 5.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 16.5 570.3%  
Shareholders   20,807 93,274 22.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   CADILA HEALTHCARE  TTK HEALTHCARE  NEULAND LABS  BIOCON   J.B.CHEMICALS  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Share Markets Open Higher; JSW Steel & Tata Steel Top Gainers(09:30 am)

Asian share markets edged higher today as investors shrugged off concerns that stocks may have rallied too far too fast in the past year.

Related Views on News

PIRAMAL ENTERPRISES at 52 Week High; BSE 500 Index Up 1.0% (Market Updates)

Mar 3, 2021 | Updated on Mar 3, 2021

PIRAMAL ENTERPRISES share price has hit a 52-week high. It is presently trading at Rs 1,969. BSE 500 Index is up by 0.9% at 20,109. Within the BSE 500, PIRAMAL ENTERPRISES (up 2.6%) and IFCI (up 11.8%) are among the top gainers, while top losers are IRCON INTERNATIONAL and MMTC.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY21); Net Profit Up 22.1% (Quarterly Result Update)

Aug 25, 2020 | Updated on Aug 25, 2020

For the quarter ended June 2020, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 22.1% YoY). Sales on the other hand came in at Rs 29 bn (down 16.2% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY20); Net Profit Up 11.7% (Quarterly Result Update)

Feb 5, 2020 | Updated on Feb 5, 2020

For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS